{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:federal-register-2014-23961:v1","objectPathId":"federal-register-2014-23961-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/federal-register-2014-23961/","json":"https://peptidescanner.com/evidence/v1/objects/federal-register-2014-23961-v1.json","markdown":"https://peptidescanner.com/evidence/v1/objects/federal-register-2014-23961-v1.md"},"story":{"slug":"federal-register-2014-23961","version":1,"domain":"Regulatory","dateInSource":"2014-10-08","sourceCheckedAt":"2026-08-21","publishedAt":"2026-08-21","peptideSlugs":["leuprolide"],"peptides":[{"slug":"leuprolide","url":"https://peptidescanner.com/peptides/leuprolide/"}]},"claims":[{"id":"headline","text":"Federal Register notice 2014-23961","sourceIds":["federal-register-2014-23961-97a9930e6662"]},{"id":"summary","text":"The Federal Register published notice 2014-23961, attributed to FDA and its parent HHS department, on 2014-10-08. Its official title is “Determination That LUPRON DEPOT (Leuprolide Acetate for Depot Suspension), Injectable 3.75 Milligrams/Vial Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness,” and PeptideScanner's exact reviewed identity mapping connects the document to Leuprolide.","sourceIds":["federal-register-2014-23961-97a9930e6662"]},{"id":"paragraph-1","text":"The Federal Register published notice 2014-23961, attributed to FDA and its parent HHS department, on 2014-10-08. Its official title is “Determination That LUPRON DEPOT (Leuprolide Acetate for Depot Suspension), Injectable 3.75 Milligrams/Vial Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness,” and PeptideScanner's exact reviewed identity mapping connects the document to Leuprolide.","sourceIds":["federal-register-2014-23961-97a9930e6662"]},{"id":"paragraph-2","text":"This page reports bounded metadata from a Federal Register document attributed to FDA and its parent HHS department, and links to the official GovInfo PDF. It does not interpret legal effect, approval, safety, effectiveness, compounding status, or medical use.","sourceIds":["federal-register-2014-23961-97a9930e6662"]}],"sources":[{"id":"federal-register-2014-23961-97a9930e6662","name":"Federal Register via GovInfo","sourceClass":"A","title":"Federal Register notice 2014-23961 · published 2014-10-08 · Determination That LUPRON DEPOT (Leuprolide Acetate for Depot Suspension), Injectable 3.75 Milligrams/Vial Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness","url":"https://www.govinfo.gov/content/pkg/FR-2014-10-08/pdf/2014-23961.pdf"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"e8827f46418315af6b5502df36468221f67da4a5e9875af5edf9f99c6891fba0","tierARecordSha256":"97a9930e6662538b1ebe6e0b85b726023f231f7e7de00943fd84afe335c42768"},"integrity":{"algorithm":"sha256","contentSha256":"606776a8ad066a1357c2716ec213601f87db58d5b9478b4d4afd35d860ae9674"}}